Bialogics accepted into MaRS Health Ventures
August 8, 2018
TORONTO – Bialogics Analytics is pleased to announce that it has been accepted into the MaRS Health venture services program. Bialogics brings its deep understanding of the operational and performance processes of diagnostic imaging systems, with the ability to collect, structure and present data into insightful information.
MaRS Health connects small- to mid-sized companies like Bialogics with the capital, customers and talent they need to grow, and also offers a range of expert mentorship and advisory services. MaRS will help Bialogics with further product development, technology partnerships and expansion into international markets.
While working with MaRS, Bialogics will look to develop a new take on the DI ecosystem, where data can be pulled across multiple silos, provide deeper insight through data utilization and continue to develop its innovative AI Ready Business Intelligence platform for analytics, dashboard reporting, and Machine Learning capabilities.
MaRS Discovery District (@MaRSDD) in Toronto is North America’s largest urban innovation hubs. Our purpose is to help innovators change the world. MaRS supports promising ventures tackling key challenges in the health, cleantech, fintech, and enterprise sectors as they start, grow and scale. In addition, the MaRS community fosters cross-disciplinary collaboration to drive breakthrough discoveries and new solutions to be adopted in Canada and beyond, growing our economy and delivering societal impact at scale.